Partial Least Squares Based Gene Expression Analysis in EBV-Positive and EBV-Negative Posttransplant Lymphoproliferative Disorders |
Wu, Sa
(Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine)
Zhang, Xin (Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine) Li, Zhi-Ming (Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine) Shi, Yan-Xia (Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine) Huang, Jia-Jia (Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine) Xia, Yi (Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine) Yang, Hang (Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine) Jiang, Wen-Qi (Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine) |
1 | Adamson AL, Kenney S (1999). The Epstein-Barr virus BZLF1 protein interacts physically and functionally with the histone acetylase CREB-binding protein. J Virol, 73, 6551-8. |
2 | Ashburner M, Ball CA, Blake JA, et al (2000). Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat Genet, 25, 25-9. DOI ScienceOn |
3 | Auer RL, Dighiero G, Goldin LR, et al (2007). Trinucleotide repeat dynamic mutation identifying susceptibility in familial and sporadic chronic lymphocytic leukaemia. Br J Haematol, 136, 73-9. DOI ScienceOn |
4 | Chakraborty S, Datta S, Datta S (2012). Surrogate variable analysis using partial least squares (SVA-PLS) in gene expression studies. Bioinformatics, 28, 799-806. DOI ScienceOn |
5 | Craig FE, Johnson LR, Harvey SA, et al (2007). Gene expression profiling of Epstein-Barr virus-positive and -negative monomorphic B-cell posttransplant lymphoproliferative disorders. Diagn Mol Pathol, 16, 158-68. DOI ScienceOn |
6 | Gosselin. R, Rodrigue. D, Duchesne C (2010). A Bootstrap-VIP approach for selecting wavelength intervals in spectral imaging applications. Chemometrics and Intelligent Laboratory Systems, 100, 12-21. DOI ScienceOn |
7 | Gottschalk S, Rooney CM, Heslop HE (2005). Post-transplant lymphoproliferative disorders. Annu Rev Med, 56, 29-44. DOI ScienceOn |
8 | Shannon P, Markiel A, Ozier O, et al (2003). Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res, 13, 2498-504. DOI ScienceOn |
9 | Shi M, Gan YJ, Davis TO, Scott RS (2013). Downregulation of the polyamine regulator spermidine/spermine N-acetyltransferase by Epstein-Barr virus in a Burkitt's lymphoma cell line. Virus Res. |
10 | Stelzl U, Worm U, Lalowski M, et al (2005). A human protein-protein interaction network: a resource for annotating the proteome. Cell, 122, 957-68. DOI ScienceOn |
11 | Wang L, Grossman SR, Kieff E (2000). Epstein-Barr virus nuclear protein 2 interacts with p300, CBP, and PCAF histone acetyltransferases in activation of the LMP1 promoter. Proc Natl Acad Sci U S A, 97, 430-5. DOI |
12 | Martins JPA, Teofilo RF, Ferreira MMC (2010). Computational performance and cross-validation error precision of five PLS algorithms using designed and real data sets. Journal of Chemometrics, 24, 320-32. |
13 | Irizarry RA, Hobbs B, Collin F, et al (2003). Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics, 4, 249-64. DOI ScienceOn |
14 | Ji G, Yang Z, You W (2011). PLS-Based Gene Selection and Identification of Tumor-Specific Genes. Ieee Transactions On Systems, Man, And Cybernetics-Part C: Applications And Reviews, 41, 830-41. DOI ScienceOn |
15 | Kanehisa M, Goto S (2000). KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res, 28, 27-30. DOI ScienceOn |
16 | Morscio J, Dierickx D, Ferreiro JF, et al (2013). Gene expression profiling reveals clear differences between EBV-positive and EBV-negative posttransplant lymphoproliferative disorders. Am J Transplant, 13, 1305-16. DOI ScienceOn |
17 | Nelson BP, Nalesnik MA, Bahler DW, et al (2000). Epstein-Barr virus-negative post-transplant lymphoproliferative disorders: a distinct entity? Am J Surg Pathol, 24, 375-85. DOI ScienceOn |
18 | Nicewonger J, Suck G, Bloch D, Swaminathan S (2004). Epstein-Barr virus (EBV) SM protein induces and recruits cellular Sp110b to stabilize mRNAs and enhance EBV lytic gene expression. J Virol, 78, 9412-22. DOI ScienceOn |
19 | Paya CV, Fung JJ, Nalesnik MA, et al (1999). Epstein-Barr virus-induced posttransplant lymphoproliferative disorders. ASTS/ASTP EBV-PTLD Task Force and The Mayo Clinic Organized International Consensus Development Meeting. Transplantation, 68, 1517-25. DOI ScienceOn |